Annual EPS
-$30.00
+$97.80+76.53%
December 31, 2023
Summary
- As of February 7, 2025, GLMD annual earnings per share is -$30.00, with the most recent change of +$97.80 (+76.53%) on December 31, 2023.
- During the last 3 years, GLMD annual EPS has risen by +$213.00 (+87.65%).
- GLMD annual EPS is now at all-time high.
Performance
GLMD EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$27.72
-$25.56-1183.33%
September 30, 2024
Summary
- As of February 7, 2025, GLMD quarterly earnings per share is -$27.72, with the most recent change of -$25.56 (-1183.33%) on September 30, 2024.
- Over the past year, GLMD quarterly EPS has increased by +$13.44 (+32.65%).
- GLMD quarterly EPS is now -1183.33% below its all-time high of -$2.16, reached on June 30, 2024.
Performance
GLMD Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$37.43
+$13.44+26.42%
September 30, 2024
Summary
- As of February 7, 2025, GLMD TTM earnings per share is -$37.43, with the most recent change of +$13.44 (+26.42%) on September 30, 2024.
- Over the past year, GLMD TTM EPS has increased by +$46.09 (+55.18%).
- GLMD TTM EPS is now -73.69% below its all-time high of -$21.55, reached on March 31, 2013.
Performance
GLMD TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
GLMD EPS Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +76.5% | +32.6% | +55.2% |
3 y3 years | +87.7% | +32.6% | +55.2% |
5 y5 years | +69.1% | +32.6% | +55.2% |
GLMD EPS Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +87.4% | -1183.3% | +48.7% | at high | +84.2% |
5 y | 5-year | at high | +87.7% | -1183.3% | +67.9% | at high | +86.2% |
alltime | all time | at high | +89.8% | -1183.3% | +89.2% | -73.7% | +90.2% |
Galmed Pharmaceuticals EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$27.72(+1183.3%) | -$37.43(-26.4%) |
Jun 2024 | - | -$2.16(-21.7%) | -$50.87(-15.4%) |
Mar 2024 | - | -$2.76(-42.4%) | -$60.11(-14.5%) |
Dec 2023 | -$30.00(-76.5%) | -$4.79(-88.4%) | -$70.31(-15.8%) |
Sep 2023 | - | -$41.16(+261.1%) | -$83.52(+3.6%) |
Jun 2023 | - | -$11.40(-12.0%) | -$80.64(-16.2%) |
Mar 2023 | - | -$12.96(-28.0%) | -$96.24(-24.4%) |
Dec 2022 | -$127.80(-46.2%) | -$18.00(-53.0%) | -$127.32(-22.0%) |
Sep 2022 | - | -$38.28(+41.8%) | -$163.32(-9.7%) |
Jun 2022 | - | -$27.00(-38.7%) | -$180.84(-15.2%) |
Mar 2022 | - | -$44.04(-18.4%) | -$213.24(-10.3%) |
Dec 2021 | -$237.60(-2.2%) | -$54.00(-3.2%) | -$237.60(-12.0%) |
Sep 2021 | - | -$55.80(-6.1%) | -$270.00(-0.7%) |
Jun 2021 | - | -$59.40(-13.2%) | -$271.80(+4.9%) |
Mar 2021 | - | -$68.40(-20.8%) | -$259.20(+6.7%) |
Dec 2020 | -$243.00(+39.2%) | -$86.40(+50.0%) | -$243.00(+7.1%) |
Sep 2020 | - | -$57.60(+23.1%) | -$226.80(+9.6%) |
Jun 2020 | - | -$46.80(-10.3%) | -$207.00(+5.5%) |
Mar 2020 | - | -$52.20(-25.6%) | -$196.20(+12.4%) |
Dec 2019 | -$174.60(+79.6%) | -$70.20(+85.7%) | -$174.60(+27.6%) |
Sep 2019 | - | -$37.80(+5.0%) | -$136.80(+26.7%) |
Jun 2019 | - | -$36.00(+17.6%) | -$108.00(+5.3%) |
Mar 2019 | - | -$30.60(-5.6%) | -$102.60(0.0%) |
Dec 2018 | -$97.20 | -$32.40(+260.0%) | -$102.60(-13.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2018 | - | -$9.00(-70.6%) | -$118.80(-21.4%) |
Jun 2018 | - | -$30.60(0.0%) | -$151.20(-5.6%) |
Mar 2018 | - | -$30.60(-37.0%) | -$160.20(-9.2%) |
Dec 2017 | -$176.40(-34.2%) | -$48.60(+17.4%) | -$176.40(-11.7%) |
Sep 2017 | - | -$41.40(+4.5%) | -$199.80(-9.0%) |
Jun 2017 | - | -$39.60(-15.4%) | -$219.60(-12.2%) |
Mar 2017 | - | -$46.80(-35.0%) | -$250.20(-6.7%) |
Dec 2016 | -$268.20(+55.2%) | -$72.00(+17.6%) | -$268.20(+8.0%) |
Sep 2016 | - | -$61.20(-12.8%) | -$248.40(+8.7%) |
Jun 2016 | - | -$70.20(+8.3%) | -$228.60(+16.5%) |
Mar 2016 | - | -$64.80(+24.1%) | -$196.20(+14.7%) |
Dec 2015 | -$172.80(+9.1%) | -$52.20(+26.1%) | -$171.00(+14.5%) |
Sep 2015 | - | -$41.40(+9.5%) | -$149.40(-6.7%) |
Jun 2015 | - | -$37.80(-4.5%) | -$160.20(+8.5%) |
Mar 2015 | - | -$39.60(+29.4%) | -$147.60(-5.7%) |
Dec 2014 | -$158.40(-46.3%) | -$30.60(-41.4%) | -$156.60(-59.2%) |
Sep 2014 | - | -$52.20(+107.1%) | -$383.37(+8.1%) |
Jun 2014 | - | -$25.20(-48.1%) | -$354.67(-2.4%) |
Mar 2014 | - | -$48.60(-81.1%) | -$363.31(+8.0%) |
Dec 2013 | -$294.84(+163.7%) | -$257.37(+994.9%) | -$336.27(+326.2%) |
Sep 2013 | - | -$23.51(-30.5%) | -$78.90(+42.4%) |
Jun 2013 | - | -$33.84(+57.0%) | -$55.39(+157.0%) |
Mar 2013 | - | -$21.55 | -$21.55 |
Dec 2012 | -$111.81 | - | - |
FAQ
- What is Galmed Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual EPS year-on-year change?
- What is Galmed Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly EPS year-on-year change?
- What is Galmed Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM EPS year-on-year change?
What is Galmed Pharmaceuticals annual earnings per share?
The current annual EPS of GLMD is -$30.00
What is the all time high annual EPS for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual earnings per share is -$30.00
What is Galmed Pharmaceuticals annual EPS year-on-year change?
Over the past year, GLMD annual earnings per share has changed by +$97.80 (+76.53%)
What is Galmed Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of GLMD is -$27.72
What is the all time high quarterly EPS for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly earnings per share is -$2.16
What is Galmed Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, GLMD quarterly earnings per share has changed by +$13.44 (+32.65%)
What is Galmed Pharmaceuticals TTM earnings per share?
The current TTM EPS of GLMD is -$37.43
What is the all time high TTM EPS for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM earnings per share is -$21.55
What is Galmed Pharmaceuticals TTM EPS year-on-year change?
Over the past year, GLMD TTM earnings per share has changed by +$46.09 (+55.18%)